STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.
A fat activist explains why she objects to the medicalization of larger bodies and the idea that obesity is a disease.
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...
"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...
The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...
Breaking the silence on how generational trauma impacts obesity in Black communities, through one woman's powerful journey ...
Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
A significant percentage of adolescents in the United States are living with hyperuricemia, a condition that is associated with obesity and risks for cardiometabolic complications, according to study ...
Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...
Combined exposure to dioxins and dioxin-like polychlorinated biphenyls (DL-PCBs) is significantly associated with an ...
Country may have reached its peak for obesity levels, according to one of biggest online sellers of medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback